Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Update

Vivos Therapeutics, Inc. (NASDAQ:VVOS) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 249,000 shares, a drop of 27.6% from the February 28th total of 344,000 shares. Currently, 5.4% of the company’s shares are short sold. Based on an average trading volume of 210,600 shares, the short-interest ratio is presently 1.2 days.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Cutter & CO Brokerage Inc. bought a new stake in shares of Vivos Therapeutics in the 4th quarter worth about $163,000. Commonwealth Equity Services LLC raised its position in Vivos Therapeutics by 23.8% in the 4th quarter. Commonwealth Equity Services LLC now owns 26,000 shares of the company’s stock worth $112,000 after purchasing an additional 5,000 shares during the period. Geode Capital Management LLC lifted its stake in Vivos Therapeutics by 55.6% in the fourth quarter. Geode Capital Management LLC now owns 44,827 shares of the company’s stock worth $192,000 after purchasing an additional 16,025 shares during the last quarter. Finally, Anson Funds Management LP purchased a new position in shares of Vivos Therapeutics during the fourth quarter valued at approximately $1,041,000. Institutional investors own 26.35% of the company’s stock.

Vivos Therapeutics Price Performance

Shares of VVOS stock opened at $3.11 on Monday. The company has a market cap of $18.32 million, a PE ratio of -0.55 and a beta of 7.47. Vivos Therapeutics has a 1 year low of $1.91 and a 1 year high of $6.28. The stock’s 50 day simple moving average is $3.78 and its two-hundred day simple moving average is $3.61.

About Vivos Therapeutics

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.